Cargando…
Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785719/ https://www.ncbi.nlm.nih.gov/pubmed/33424669 http://dx.doi.org/10.3389/fpsyt.2020.612347 |
| _version_ | 1783632480871383040 |
|---|---|
| author | Muric, Nemanja N. Arsenijevic, Nebojsa N. Borovcanin, Milica M. |
| author_facet | Muric, Nemanja N. Arsenijevic, Nebojsa N. Borovcanin, Milica M. |
| author_sort | Muric, Nemanja N. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7785719 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77857192021-01-07 Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment Muric, Nemanja N. Arsenijevic, Nebojsa N. Borovcanin, Milica M. Front Psychiatry Psychiatry Frontiers Media S.A. 2020-12-23 /pmc/articles/PMC7785719/ /pubmed/33424669 http://dx.doi.org/10.3389/fpsyt.2020.612347 Text en Copyright © 2020 Muric, Arsenijevic and Borovcanin. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Psychiatry Muric, Nemanja N. Arsenijevic, Nebojsa N. Borovcanin, Milica M. Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment |
| title | Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment |
| title_full | Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment |
| title_fullStr | Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment |
| title_full_unstemmed | Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment |
| title_short | Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment |
| title_sort | chlorpromazine as a potential antipsychotic choice in covid-19 treatment |
| topic | Psychiatry |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785719/ https://www.ncbi.nlm.nih.gov/pubmed/33424669 http://dx.doi.org/10.3389/fpsyt.2020.612347 |
| work_keys_str_mv | AT muricnemanjan chlorpromazineasapotentialantipsychoticchoiceincovid19treatment AT arsenijevicnebojsan chlorpromazineasapotentialantipsychoticchoiceincovid19treatment AT borovcaninmilicam chlorpromazineasapotentialantipsychoticchoiceincovid19treatment |